ruxolitinib phosphate

Spain

Drugs containing this active substance

  • JAKAVI 5 MG/ML ORAL SOLUTION

    It is used to treat acute graft-versus-host disease (aGVHD) in children 28 days of age or older and adults, as well as chronic graft-versus-host disease (cGVHD) in children 6 months of age or older and adults.

    Form: solution, oral

    Active substance Dosage
    ruxolitinib phosphate 6,60 mg/ml

    ATC: L01E L01EJ L01EJ01

    Manufacturer: Novartis Europharm Limited

  • OPZELURA 15 MG/G CREAM

    It is used on the skin to treat vitiligo affecting the face in adults and adolescents aged 12 years and older.

    Form: cream

    Active substance Dosage
    ruxolitinib phosphate 1,98 g

    ATC: D11A D11AH D11AH09

    Manufacturer: Incyte Biosciences Distribution B.V.